Economic implications of comorbid conditions among Medicaid beneficiaries with COPD

Respiratory Medicine

Volumn 104, Issue 5, 2010, Pages 697-704

  Lin, Pei Jung ^a   Shaya, Fadia T ^b   Scharf, Steven M ^c  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Comorbidity; COPD; Cost; Medicaid; Utilization

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEPRESSION; ECONOMIC ASPECT; ECONOMIC EVALUATION; EDEMA; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAID; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SLEEP APNEA SYNDROME; TOBACCO DEPENDENCE; UNITED STATES; ECONOMICS; HEALTH SERVICE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA;

CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MARYLAND; MEDICAID; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 77951621435     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.11.009     Document Type: Article

References (24)

1. NHLBI. Morbidity and Mortality chart book: chart book on cardiovascular, lung, and blood diseases; 2007.
2. Centers for Disease Control and Prevention. Leading causes of death (2008). http://www.cdc.gov/nchs/FASTATS/lcod.htm [accessed 1.03.09]
3. van Manen J.G., Bindels P.J., van der Zee J.S., Ij C.j., Bottema B.J., and Schade E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 54 3 (2001) 287-293
4. Mapel D.W., Hurley J.S., Frost F.J., Petersen H.V., Picchi M.A., and Coultas D.B. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med 160 17 (2000) 2653-2658
5. Crisafulli E., Costi S., Luppi F., et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax 63 6 (2008) 487-492
6. Vilkman S., Keistinen T., Tuuponen T., and Kivela S.L. Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital. Respiration 64 4 (1997) 281-284
7. McGhan R., Radcliff T., Fish R., Sutherland E.R., Welsh C., and Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 132 6 (2007) 1748-1755
8. Yeo J., Karimova G., and Bansal S. Co-morbidity in older patients with COPD - its impact on health service utilisation and quality of life, a community study. Age Ageing 35 1 (2006) 33-37
9. Wijnhoven H.A., Kriegsman D.M., Hesselink A.E., de Haan M., and Schellevis F.G. The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med 97 5 (2003) 468-475
10. Sin D.D., Anthonisen N.R., Soriano J.B., and Agusti A.G. Mortality in COPD: role of comorbidities. Eur Respir J 28 6 (2006) 1245-1257
11. Krachman S., Minai O.A., and Scharf S.M. Sleep abnormalities and treatment in emphysema. Proc Am Thorac Soc 5 4 (2008) 536-542
12. Shaya F.T., Lin P.J., Aljawadi M.H., and Scharf S.M. Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome. Sleep Breath 13 4 (2009) 315-316
13. Shaya F.T., Dongyi D., Akazawa M.O., et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest 134 1 (2008) 14-19
14. Blanchette C.M., Gutierrez B., Ory C., Chang E., and Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a medicare advantage population. J Manag Care Pharm 14 2 (2008) 176-185
15. Grasso M.E., Weller W.E., Shaffer T.J., Diette G.B., and Anderson G.F. Capitation, managed care, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 1 (1998) 133-138
16. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 5 (1987) 373-383
17. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 6 (1992) 613-619
18. Mapel D.W., Frost F.J., Hurley J.S., et al. An algorithm for the identification of undiagnosed COPD cases using administrative claims data. J Manag Care Pharm 12 6 (2006) 457-465
19. Akazawa M., Halpern R., Riedel A.A., Stanford R.H., Dalal A., and Blanchette C.M. Economic burden prior to COPD diagnosis: a matched case-control study in the United States. Respir Med 102 12 (2008) 1744-1752
20. NHLBI. Who is at risk for high blood pressure? (2008). http://www.nhlbi.nih.gov/health/dci/Diseases/Hbp/HBP_WhoIsAtRisk.html [accessed 1.03.09]
21. Holguin F., Folch E., Redd S.C., and Mannino D.M. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 128 4 (2005) 2005-2011
22. Barr R.G., Celli B.R., Martinez F.J., et al. Physician and patient perceptions in COPD: the COPD resource network needs assessment survey. Am J Med 118 12 (2005) 1415
23. Sidney S., Sorel M., Quesenberry Jr. C.P., DeLuise C., Lanes S., and Eisner M.D. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 128 4 (2005) 2068-2075
24. Mapel D.W., Robinson S.B., Dastani H.B., Shah H., Phillips A.L., and Lydick E. The direct medical costs of undiagnosed chronic obstructive pulmonary disease. Value Health 11 4 (2008) 628-636